Literature DB >> 3486012

Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia.

J D Griffin, D Young, F Herrmann, D Wiper, K Wagner, K D Sabbath.   

Abstract

Proliferation of acute myeloblastic leukemia (AML) cells in vitro is limited in most cases to a small subset of blasts that have several properties of stem cells. These leukemic colony-forming cells (AML-CFU) generally require addition of exogenous growth factors for proliferation in agar or methylcellulose. These factors can be supplied by media conditioned by phytohemagglutinin-stimulated normal leukocytes or by CSF-secreting tumor cell lines. However, the exact factor or factors required for stimulation of AML-CFU growth have not been defined. We compared the AML-CFU stimulatory activity of a human recombinant GM-CSF with that of GCT-CM, Mo-CM, and the PHA-leukocyte feeder system in 15 cases of AML. In each of the 12 cases that required exogenous growth factors for maximum AML-CFU growth, recombinant GM-CSF could replace either GM-CSF or Mo-CM, and could partially replace the PHA-leukocyte feeder system. These results indicate that this GM-CSF is a growth promoter of AML-CFU in these culture systems.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486012

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Monosomy 7 provides a proliferative advantage for leukemic cells under incubation with GM-CSF in vitro.

Authors:  D Haase; C Fonatsch
Journal:  Blut       Date:  1990-11

Review 2.  Preclinical and clinical studies with the hematopoietic colony-stimulating factors and related interleukins.

Authors:  H E Broxmeyer; S Vadhan-Raj
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 3.  Recombinant methionyl granulocyte colony-stimulating factor (filgrastim): a new dimension in immunotherapy.

Authors:  G Schwab; T Hecht
Journal:  Ann Hematol       Date:  1994-07       Impact factor: 3.673

Review 4.  The role of colony-stimulating factors in acute leukemia.

Authors:  F Herrmann; E Vellenga
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

5.  Hematopoietic growth factors.

Authors:  C A Sieff
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

6.  Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.

Authors:  W Oster; N A Cicco; H Klein; T Hirano; T Kishimoto; A Lindemann; R H Mertelsmann; F Herrmann
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

7.  Recombinant human colony stimulating factor-granulocyte/macrophage and -granulocyte, but not macrophage induce the development of a respiratory burst in primary human myeloid leukemic cells in vitro.

Authors:  K Geissler; G Tricot; G Grimm; P Siostrzonek; H Broxmeyer
Journal:  Blut       Date:  1989-09

Review 8.  Use and toxicity of the colony-stimulating factors.

Authors:  J R Schriber; R S Negrin
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

Review 9.  Acute myeloid leukemia in the elderly: biological features and search for adequate treatment.

Authors:  V Heinemann; U Jehn
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

10.  Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia.

Authors:  D C Young; K Wagner; J D Griffin
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.